back to conferences

Global NASH Congress 2021

date

April 28-19, 2021

location

Virtual

In 2021 the Global NASH conference will once again explore the advances being made in research and development in pathogenesis, diagnosis and treatment of non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). A multi-disciplinary speaker panel will give their insights on these developments as well as reporting on clinical trials.

This program creates a collaborative environment to foster the creation of enduring relationships across the full range of disciplines engaged in NASH research & drug discovery and development.

  • Learn how to integrate NAFLD Screening into secondary and tertiary care
  • Discover the regulatory pathways for approval of biomarkers in NAFLD patients
  • Review the current and potential biomarkers for staging
  • Investigate if targeting fructose metabolism offers a NAFLD/NASH therapy
  • Hear how belapectin, a galectin-3 (Gal-3) inhibitor, is in development for the prevention of oesophagal varices in patients with NASH cirrhosis
  • Explore the Epidemiology of NAFLD

To learn more about how Simoa technology can support the study of NASH, please contact sales@quanterix.com.

For more information on the congress, please visit the event website.